CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4/A Open-market sale Chief Executive Officer sold 26,020 shares at an average $7.50 ($195,200)
- 4 Open-market sale Chief Executive Officer sold 200 shares at $7.55 ($1,510)
- 4 Open-market sale Chief Executive Officer sold 1,935 shares at $7.50 ($14,513)
- 4 Open-market sale Chief Executive Officer sold 12,661 shares at an average $7.50 ($94,997)
- 4/A Open-market sale Chief Executive Officer sold 11,224 shares at $7.50 ($84,180)
- 4 Open-market sale Chief Executive Officer sold 15,224 shares at $7.50 ($114,180)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 82,243 shares at $8.25 ($678,505)
- 4 Open-market sale Director sold 6,300 shares at $8.26 ($52,038)
Page 65 of 74 · 1,465 filings